HUMAN-KIDNEY THIOPURINE METHYLTRANSFERASE - PURIFICATION AND BIOCHEMICAL-PROPERTIES

HUMAN-KIDNEY THIOPURINE METHYLTRANSFERASE - PURIFICATION AND BIOCHEMICAL-PROPERTIES
复制标题

DOI:
10.1016/0006-2952(83)90582-8
复制
发表时间:
1983-01-01
影响因子:
5.8
通讯作者:
WEINSHILBOUM, RM
WEINSHILBOUM, RM
中科院分区:
医学2区
文献类型:
--
作者:
WOODSON, LC;WEINSHILBOUM, RM

文献摘要

被引文献

相似文献

硫嘌呤甲基转移酶(TPMT)催化硫嘌呤和硫嘧啶的S-甲基化。人肾TPMT纯化超过300倍,并测定其生化性质。TPMT是可溶性的,并且具有约1的MW。36,000道尔顿,通过凝胶过滤色谱法估计。纯化的TPMT的最适pH为6.7。反应的2种共底物6-巯基嘌呤(6-MP)和S-腺苷-L-甲硫氨酸(SAM)的真实Km值分别为0.30 mM和2.7 μ M。6-硫鸟嘌呤和2-硫氧嘧啶,2个其他甲基受体底物的表观Km值分别为0.55和2.0 mM。脂肪族硫醇化合物是TPMT的不良底物或未甲基化。当底物为SAM时,S-腺苷-L-同型半胱氨酸对TPMT为竞争性抑制剂,而6-甲巯基嘌呤对6-MP为非竞争性抑制剂。纯化的TPMT既不激活,也不抑制1 mM的Ca 2+或Mg 2+,但暴露于试剂,如N-乙基马来酰亚胺和ethacrynic酸,与SH基团相互作用的失活酶。托酚酮抑制TPMT,Ki为apprx。0.85最后,基于亚细胞分布、底物特异性、动力学特征和对抑制剂的不同敏感性,可以将人肾TPMT活性与人肾巯基甲基转移酶(EC2.1.1.9)活性区分开。
Thiopurine methyltransferase (TPMT) catalyzes the S-methylation of thiopurines and thiopyrimidines. Human kidney TPMT was purified over 300-fold and its biochemical properties were determined. TPMT was soluble and had a MW of .apprx. 36,000 daltons as estimated by gel filtration chromatography. The pH optimum of the purified TPMT was 6.7. True Km values for 6-mercaptopurine (6-MP) and S-adenosyl-L-methionine (SAM), the 2 cosubstrates for the reaction, were 0.30 mM and 2.7 .mu.M, respectively. Apparent Km values for 6-thioguanine and 2-thiouracil, 2 other methyl acceptor substrates, were 0.55 and 2.0 mM, respectively. Aliphatic thiol compounds were either poor substrates for TPMT or were not methylated. S-Adenosyl-L-homocysteine was a competitive inhibitor of TPMT when the varied substrate was SAM and 6-methylmercaptopurine was a noncompetitive inhibitor with respect to 6-MP. Purified TPMT was neither activated nor inhibited by 1 mM Ca2+ or Mg2+, but exposure to reagents such as N-ethylmaleimide and ethacrynic acid that interact with SH groups inactivated the enzyme. Tropolone inhibited TPMT with a Ki of .apprx. 0.85 mM. Finally, human kidney TPMT activity could be distinguished from human kidney thiol methyltransferase (EC 2.1.1.9) activity on the basis of subcellular distribution, substrate specificity, kinetic characteristics and differential sensitivity to inhibitors.